GlycoEra AG (Series B)
Funding Details
- Date Award
- May 28, 2025
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $130,000,000
Company Info
- Company Description
- GlycoEra AG is focused on developing innovative therapies for autoimmune diseases, utilizing its lead IgG4-targeted protein degrader program to advance into clinical trials.
- Market
- Autoimmune Diseases
- Location
- Wädenswil, Switzerland
- Coinvestors
- Novo Holdings, Catalio Capital Management